Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Calorie/Nitrogen PN vs Traditional PN in Postoperative GI Patients
NCT00247338Phase 4Completed
- Sponsor
- Sino-Swed Pharmaceutical Co., Ltd.
- Start
- Apr 2005
- Primary completion
- Apr 2006
- Modality
- Lipid-based Nanoparticles, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Kabiven in gastrointestinal neoplasms (2 arms), sponsored by Sino-Swed Pharmaceutical Co., Ltd. Primary endpoint: Infectious complications. Started Apr 2005; status: completed.
02
Drugs
Kabiven
03
Conditions
gastrointestinal neoplasms
Beyond the preview
Go deeper on NCT00247338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00247338.